RLY-2608
RLY-2608 is a selective mutant PI3Kα inhibitor that inhibits tumor growth in a PIK3CA mutant xenograft model.
Product Specifications
CAS Number
2733573-94-7
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
608.91
Molecular Formula
C29H14ClF5N6O2
Notes
Research use only, not for human use.
Receptor
PI3K
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
NBP2-98205AF700 0.1 mL
Rabbit Polyclonal ASAH2/N-acylsphingosine Amidohydrolase-2 Antibody [Alexa Fluor 700]
Ask
View Details 
MBS7078586 Inquire
Recombinant Phalaenopsis aphrodite subsp. formosana Cytochrome b559 subunit beta (psbF), partial
Ask
View Details MBS8806484-01 48 Well
Human YWHAz (Tyrosine 3/Tryptophan 5 Monooxygenase Activation Protein Zeta) ELISA Kit
Ask
View Details